OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
June 09, 2016
Sharing un-redacted inspection reports between FDA and EMA may reduce duplicate inspections of facilities.
June 02, 2016
FDA and bio/pharma companies get serious about continuous manufacturing to ensure product quality.
May 12, 2016
Biomedical innovation legislation may stall in 2016.
Drug manufacturing lapses undermine NIH research programs.
April 15, 2016
FDA’s breakthrough drug initiative is more popular and successful than ever.
April 07, 2016
The campaign against opioid abuse opens door to more innovative therapies.